I'm sure these preclinical experiments must have already been done by now, which means the fact we haven't heard anything is either bad news (combo doesn't work straightforwardly as of now) or good news (want to keep it under wraps).
Certainly been radio silence on the issue from all the CD47 companies.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.